Clinicogenomic Predictors of First-line Immune Checkpoint Inhibitor Outcomes in Non–Small Cell Lung Cancer: A Nationwide C CAT Cohort From Japan

Clinical Lung Cancer · Published 2026-03-10 · DOI 10.1016/j.cllc.2026.03.003

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.cllc.2026.03.003

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles